510(k) K782156
K782156 is an FDA 510(k) premarket notification submitted by Boehringer Mannheim Corp. for the device "UNITEST CREATINE KINASE". The FDA issued a decision of Substantially Equivalent on March 2, 1979. The device falls under product code JLB (Atp And Creatine Kinase (Enzymatic), Creatine), a Class I device regulated under 21 CFR 862.1210. Boehringer Mannheim Corp. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- March 2, 1979
- Date Received
- December 22, 1978
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Atp And Creatine Kinase (Enzymatic), Creatine
- Device Class
- Class I
- Regulation Number
- 862.1210
- Review Panel
- CH
- Submission Type